Sectra

By Sectra
· Sweden
Sectra — PACS platform integrating third-party AI modules, including the recently acquired Oxipit (ChestLink).
Workflow Optimization
Radiology
Production
Not Formally Regulated
Regulatory status
Not Formally Regulated
Deployment
Production
Clinical role
Adjunct (decision support)
Headquarters
Sweden
AI type
Workflow Optimization

Precise indication

PACS platform integrating third-party AI modules, including the recently acquired Oxipit (ChestLink).

Regulatory status

Not directly applicable — a PACS platform, not itself a single regulated AI device.

Clinical evidence

Vendor-supported

Sectra’s own press release confirming the Oxipit acquisition.

Independent

Not found in this research pass — verify before publishing.

Real-world deployment

Oxipit acquisition confirmed in 2026, adding autonomous chest X-ray AI to Sectra’s PACS distribution.

Interoperability

European status

Editorial verdict

Limits and uncertainties

Best evaluated together with the ChestLink/Oxipit entry, since Sectra is now its distribution channel.

Sources

https://sectra.com/news-and-press-releases/?item=3572D1FFBE251FEC

This profile is not medical advice or an endorsement. Hospitals should perform their own due diligence (regulatory compliance, GDPR, cybersecurity, integration, local clinical validation). How we evaluate

At a glance
Vendor
Sectra
Headquarters
Sweden
AI type
Workflow Optimization
Specialty
Clinical role
Adjunct (decision support)
CE marking
Notified body
EU AI Act
Data hosting
Last verified
Reviewed by
How we evaluate

Every profile documents the precise indication, regulatory status, vendor-supported and independent evidence, real-world deployment, limits and dated sources.

A independent systematic review or prospective multicentre study · B at least one independent peer-reviewed study · C peer-reviewed, vendor-supported · D vendor claims only.

Read the methodology →

Spotted an error?

Vendors, authors and clinicians can request a correction. Corrections are dated on the profile.